Ergebnisse einschränken

Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3years

Ferrari, S. ; Adachi, J. ; Lippuner, K. ; Zapalowski, C. ; Miller, P. ; Reginster, J.-Y ; Törring, O. ; Kendler, D. ; Daizadeh, N. ; Wang, A. ; O'Malley, C. ; Wagman, R. ; Libanati, C. ; Lewiecki, E.

In: Osteoporosis International, 2015, vol. 26, no. 12, p. 2763-2771

Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Ferrari-Lacraz, S. ; Ferrari, S.

In: Osteoporosis International, 2011, vol. 22, no. 2, p. 435-446

Die ossäre Metastasierung des Prostatakarzinoms = Bone metastasis in prostate cancer

Moltzahn, F. ; Thalmann, G.N.

Prävention der postmenopausalen Osteoporose : Teil2: Medikamentöse Prävention und Therapie der Osteoporose in der Peri- und frühen Postmenopause = Prevention of postmenopausal osteoporosis : Part2: pharmacological prevention and therapy of osteoporosis in the perimenopause and early postmenopause

Birkhäuser, M.